Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their Meeting held today i.e. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pervasive Commodities' Board, at its meeting on 11th February 2026, approved the unaudited financial results for Q3 FY26 and the nine months ended 31st December 2025. Revenue from operations for Q3 FY26 stood at Rs. 618 lac (vs Rs. 237.83 lac in Q3 FY25), with a net profit of Rs. 78.73 lac (vs Rs. 14.73 lac) and basic EPS of Rs. 0.01. However, the nine-month picture is deeply negative, with a net loss of Rs. 1,476.57 lac against a profit of Rs. 68.80 lac in the prior-year period, driven almost entirely by a Rs. 1,565.16 lac loss in Q2 FY26. The auditor's review highlights that the loss stemmed from the destruction of the company's entire perishable stock-in-trade during the previous quarter, and crucially, the company had no insurance coverage. The equity base has also expanded due to a Rs. 10-to-Rs. 1 stock split (record date 7th April 2025) and conversion of warrants into equity shares on 20th May 2025.
The Q3 turnaround is encouraging, but the uninsured stock loss and a 9-month loss of over Rs. 14.7 crore signal significant operational risk. Share count expansion from the stock split and warrant conversion will likely keep EPS under pressure despite any future profit recovery.